Expert Analysis

First-Line Antiretroviral Therapy

Source: CCO Independent Conference Coverage of the 2003 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

First-Line Antiretroviral Therapy

Program Director: John P. Phair, MD

Faculty:

Daniel R. Kuritzkes, MD
Kimberly Y. Smith, MD, MPH
Kathleen E. Squires, MD

CREDIT INFORMATION

Release Date: 03/06/03

Expiration Date: 03/05/04

Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe findings from recent studies comparing different antiretroviral regimens in treatment-naive subjects
Review recent data on the optimal timing of the initiation of antiretroviral therapy
Discuss the importance relevance differences in potency between options for first-line therapy

Earn CME credit by reading the expert analysis and commentary on the antiretroviral management of patients receiving therapy. Topics covered include:

Outcomes with earlier and later initiation
Improving outcomes of first-line therapy
Outcomes in women compared with men
Managing intolerance to first-line regimens
How important are differences in potency?
Options for once-daily therapy
Fosamprenavir in first-line therapy
2NN: comparision of nevirapine and efavirenz in first-line therapy
Tenofovir in first-line therapy
Treatment of primary infection
First-line therapy in resource-poor settings

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.